Home > Insider Trading > Filing (0001144204-19-036669)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484565	Soleno Therapeutics Inc	SLNO	()	NY

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
926475	N Larry Feinberg	262 Harbor Drive, 3Rd Fl Stamford CT 06902		No	No	Yes	No
941901	Oracle Partners Lp	262 Harbor Drive, 3Rd Fl Stamford CT 06902		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share ("Common Stock")	Acquisiton	2019-07-26	49,569	$2.14	2,665,050	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2019-07-26	7,500	$2.14	350,334	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	855,243	Indirect	See footnote

Footnotes

These securities are owned by Oracle Partners, LP. ("Partners").
These securities are owned by Oracle Institutional Partners, L.P. ("Institutional Partners")
These securities are owned by Oracle Ten Fund, L.P. ("Ten Fund").
Larry N. Feinberg serves as the managing member of Oracle Associates, LLC, the general partner of Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund.
Each of the Reporting Persons identified in this statement disclaims beneficial ownership of the securities described in this statement, except to the extent of their individual respective pecuniary interest in such securities. The filing of this statement shall not be deemed an admission that any of the Reporting Persons identified in this statement are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities specified in this statement other than those directly beneficially owned by them.